![]() ![]() | LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., Le Goff, C., & Cavalier, E. (2020). Parathormone, bone alkaline phosphatase and 25-hydroxyvitamin D status in a large cohort of 1200 children and teenagers. Acta Clinica Belgica, 1-6. doi:10.1080/17843286.2020.1769285 ![]() |
![]() ![]() | Cavalier, E., Huyghebaert, L., ROUSSELLE, O., BEKAERT, A.-C., KOVACS, S., VRANKEN, L., PEETERS, S., Le Goff, C., & LADANG, A. (2020). Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects. Clinical Chemistry and Laboratory Medicine, 58 (2), 197-201. doi:10.1515/cclm-2019-0996 ![]() |
![]() ![]() | LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). 24,25(OH)2D AS A MARKER OF VITAMIN D DEFICIENCY IN CHILDREN: A RETROSPECTIVE [Poster presentation]. Euromedlab 2019. |
![]() ![]() | LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). EVALUATION OF PARATHORMONE AND 25-HYDROXYVITAMIN D STATUS IN A LARGE [Poster presentation]. Euromedlab 2019. |
![]() ![]() | LADANG, A., ROUSSELLE, O., BEKAERT, A.-C., KOVACS, S., & CAVALIER, E. (May 2019). PEDIATRIC REFERENCE INTERVALS FOR BONE ALKALINE PHOSPHATASE ON LIAISON° XL [Poster presentation]. Euromedlab 2019. |
![]() ![]() | VRANKEN, L., BEKAERT, A.-C., GENDEBIEN, A.-S., & CAVALIER, E. (14 June 2017). Impact of vitamin D binding protein on calculated free 25OH vitamin D [Poster presentation]. 22 nd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Athens 2017, Athènes, Greece. |
![]() ![]() | VRANKEN, L., LE GOFF, C., BEKAERT, A.-C., GENDEBIEN, A.-S., & CAVALIER, E. (14 June 2017). Comparison of measured and calculated free 25-hydroxyvitamin D : impact of vitamin D binding protein assay and race [Poster presentation]. 22 nd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Athens 2017, Athènes, Greece. |
![]() ![]() | Cavalier, E., LUKAS, P., BEKAERT, A.-C., CARLISI, I., Le Goff, C., DELANAYE, P., & Souberbielle, J.-C. (March 2017). Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose? Clinical Chemistry and Laboratory Medicine, 55 (3), 378-384. doi:10.1515/cclm-2016-0566 ![]() |
![]() ![]() | VRANKEN, L., BEKAERT, A.-C., GENDEBIEN, A.-S., & CAVALIER, E. (14 October 2016). Impact of vitamin D binding protein on calculated free 25OH vitamin D [Paper presentation]. Annual Congress of the Royal Belgian Society of Laboratory Medecin, Seraing, Belgium. |
![]() ![]() | VRANKEN, L., BEKAERT, A.-C., GENDEBIEN, A.-S., & CAVALIER, E. (14 October 2016). Impact of vitamin D binding protein on calculated free 25OH vitamin D [Poster presentation]. Annual Congress of the Royal Belgian Society of Laboratory Medecin. |
![]() ![]() | CAVALIER, E., LUKAS, P., BEKAERT, A.-C., PEETERS, S., LE GOFF, C., Yayo, E., DELANAYE, P., & Souberbielle, J.-C. (2016). Analytical and clinical evaluation of the new Fujirebio Lumipulse G non-competitive assay for 25(OH)-vitamin D and three immunoassays for 25(OH)D in healthy subjects, osteoporotic patients, third trimester pregnant women, healthy African subjects, hemodialyzed and intensive care patients. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2015-0923 ![]() |
![]() ![]() | Castiglione, V., JOURET, F., Bruyère, O., DUBOIS, B., THOMAS, A., WALTREGNY, D., BEKAERT, A.-C., CAVALIER, E., & GADISSEUR, R. (February 2015). Epidémiologie de la lithiase urinaire sur base d'une analyse morpho-constitutionnelle. Néphrologie et Thérapeutique, 11, 42-49. doi:10.1016/j.nephro.2014.08.003 ![]() |
![]() ![]() | CAVALIER, E., GADISSEUR, R., GEBOES, S., BEKAERT, A.-C., CARLISI, I., Bruyère, O., & Reginster, J.-Y. (2015). Critical evaluation of promising markers for sarcopenia. Osteoporosis International, 26 (S1), 49-S50. ![]() |
Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., CAVALIER, E., & GADISSEUR, R. (18 October 2014). Epidemiology of urolithiasis in Liège on the basis of a morpho-constitutional classification [Poster presentation]. BVKB, Leuven, Belgium. |
![]() ![]() | Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (17 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège [Paper presentation]. Confrontations clinico-biologiques autour de la lithiase urinaire, Paris, France. |
![]() ![]() | CAVALIER, E., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., & DELANAYE, P. (October 2014). Les résultats des formules de calcul de la 25(OH)-vitamine D libre varient en fonction des méthodes de dosage de la 25(OH)D [Poster presentation]. 16ème Réunion commune - Société de néphrologie - Société de dialyse, Saint-Etienne, France. |
![]() ![]() | CAVALIER, E., DUBOIS, B., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., KRZESINSKI, J.-M., & DELANAYE, P. (October 2014). La membrane de dialyse peut-elle avoir une influence sur le statut en vitamine D du patient? [Poster presentation]. 16ème réunion commune - Société de néphrologie - Société de dialyse, Saint Etienne, France. |
![]() ![]() | Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (01 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270. ![]() |
![]() ![]() | GADISSEUR, R., Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., & CAVALIER, E. (September 2014). Epidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270. ![]() |
![]() ![]() | Morovat, A., Catchpole, A., MEURISSE, A., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., paddon, M., James, T., & CAVALIER, E. (October 2013). IDS iSYS automated intact procollagen-1-Nterminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clinical Chemistry and Laboratory Medicine, 51 (10), 2009-2018. doi:10.1515/cclm-2012-0531 ![]() |
![]() ![]() | CAVALIER, E., LE GOFF, C., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., DELANAYE, P., & Souberbielle, J.-C. (May 2013). Comparison of the total error obtained with six immuno-assays for 25-hydroxy vitamin D with the minimal, desirable and optimal total allowable errors calculated according to the biological variation. Biochimica Clinica, 37 (SS), 259. ![]() |
![]() ![]() | CAVALIER, E., DELANAYE, P., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., & MORANNE, O. (17 July 2012). Variability of Different Markers of Bone mineral Metabolism in Hemodialysis PAtients: Implication on the Evaluation of the Critical Difference between two Measurements [Poster presentation]. AACC 2012, Los Angeles, United States. |
![]() ![]() | CAVALIER, E., CARLISI, I., FERRANTE, N., BEKAERT, A.-C., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Performance of the IDS-iSYS CROSSLAPS (CTX-I) Automated Immunoassay [Poster presentation]. AACC 2012, Los Angeles, United States. |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., & Chapelle, J.-P. (18 February 2012). Human anti-animal interference in DiaSorin Liaison total 25(OH)-vitamin D assay: Towards the end of a strange story? Clinica Chimica Acta, 413 (3-4), 527-528. doi:10.1016/j.cca.2011.11.014 ![]() |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (18 January 2012). New insights on the stability of the Parathyroid hormone as assayed by an automated 3rd generation PTH assay. Clinica Chimica Acta, 413 (1-2), 353-4. doi:10.1016/j.cca.2011.09.034 ![]() |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & Souberbielle, J.-C. (2012). Analytical evaluation of the new Abbott Architect 25-OH vitamin D assay. Clinical Biochemistry, 45, 505-508. doi:10.1016/j.clinbiochem.2012.01.021 ![]() |
![]() ![]() | CAVALIER, E., DELANAYE, P., VRANKEN, L., BEKAERT, A.-C., CARLISI, I., Chapelle, J.-P., & SOUBERBIELLE, J.-C. (2012). Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Nephrology Dialysis Transplantation, 27, 1950-56. doi:10.1093/ndt/gfr535 ![]() |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (October 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay. Clinical Chemistry, 57 (S10), 190. ![]() |
![]() ![]() | CAVALIER, E., DELANAYE, P., VRANKEN, L., CARLISI, I., BEKAERT, A.-C., Chapelle, J.-P., & Souberbielle, J.-C. (October 2011). Impact of the use of the Manufacture's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines. Clinical Chemistry, 57 (S10), 191. ![]() |
![]() ![]() | CAVALIER, E., BEKAERT, A.-C., CARLISI, I., & CHAPELLE, J.-P. (17 September 2011). Automated Measurement of Total 25OH Vitamin D in the IDS iSYS System [Poster presentation]. ASBMR 2011 Annual Meeting, San-Diego, United States. |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (28 July 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay [Poster presentation]. AACC, Atlanta, United States. |
![]() ![]() | CAVALIER, E., DELANAYE, P., Vranken, L., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & Souberbielle, J.-C. (28 July 2011). Impact of the use of the Manufacturer's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines [Poster presentation]. AACC, Atlanta, United States. |
![]() ![]() | Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Chapelle, J.-P., & Delanaye, P. (2011). Analytical validation of the Liaison Calcitonin_II-Gen (DiaSorin). Clinical Chemistry and Laboratory Medicine, 49 (2), 271-275. doi:10.1515/CCLM.2011.036 ![]() |
![]() ![]() | Cavalier, E., Bekaert, A.-C., Carlisi, I., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2011). Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite Triage? The laboratory's point of view. Clinical Chemistry and Laboratory Medicine, 49 (2), 339-341. doi:10.1515/CCLM.2011.044 ![]() |
![]() ![]() | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & SOUBERBIELLE, J.-C. (2011). Validation of the Abbott Architect 25(OH)-vitamin D assay. Clinical Chemistry and Laboratory Medicine, 49 (s1), 418. ![]() |
![]() ![]() | Cavalier, E., Rozet, E., Bekaert, A.-C., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (September 2010). Le dosage urinaire et plasmatique du NGAL: étude analytique et implications pratiques pour le clinicien. Néphrologie et Thérapeutique, 6 (5), 350. ![]() |
![]() ![]() | Cavalier, E., Saarbach, D., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Analytical validation of the Abbott Architect urine NGAL. Clinical Chemistry, 56 (S6), 96. ![]() |
![]() ![]() | Cavalier, E., Rousselle, O., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the determination of the 3rd Generation PTH. Clinical Chemistry, 56 (S6), 56. ![]() |
![]() ![]() | Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Delanaye, P., & Chapelle, J.-P. (June 2010). Evaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination. Clinical Chemistry, 56 (S6), 188. ![]() |
![]() ![]() | Cavalier, E., Saarbach, D., Bekaert, A.-C., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2010). Urinary or plasma NGAL?: Analytical point of view. Acta Clinica Belgica. ![]() |
![]() ![]() | Cavalier, E., Bekaert, A.-C., Legrand, D., Rozet, E., Krzesinski, J.-M., & Delanaye, P. (2010). Urinary NGAL: Use of absolute value or ratio to creatinine? Acta Clinica Belgica, 65-3, 13. ![]() |
![]() ![]() | Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Hubert, P., Chapelle, J.-P., & Delanaye, P. (January 2010). Analytical validation of the BAP OSTASE on Liaison (DiaSorin). Clinical Chemistry and Laboratory Medicine, 48 (1), 67-72. doi:10.1515/CCLM.2010.019 ![]() |
![]() ![]() | Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Chapelle, J.-P., & Delanaye, P. (June 2009). ANALYTICAL PERFORMANCE OF THE C-TERMINAL FGF-23 (IMMUTOPICS). Clinical Chemistry and Laboratory Medicine, 47 (M-A032). ![]() |
![]() ![]() | Cavalier, E., Delanaye, P., Bekaert, A.-C., Carlisi, I., & Chapelle, J.-P. (June 2009). Establishment of a reference range for the Bone Alkaline Phosphatase (BAP) with Diasorin Liaison in a biologically well-designed population. Clinical Chemistry, 55 (S6), 178. ![]() |